Novocol Chemical Mfg. Co. v. Powers & Anderson Dental Co.

128 F.2d 904, 54 U.S.P.Q. (BNA) 40, 1942 U.S. App. LEXIS 3751
CourtCourt of Appeals for the Fourth Circuit
DecidedJune 15, 1942
DocketNo. 4848
StatusPublished
Cited by6 cases

This text of 128 F.2d 904 (Novocol Chemical Mfg. Co. v. Powers & Anderson Dental Co.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Novocol Chemical Mfg. Co. v. Powers & Anderson Dental Co., 128 F.2d 904, 54 U.S.P.Q. (BNA) 40, 1942 U.S. App. LEXIS 3751 (4th Cir. 1942).

Opinion

PAUL, District Judge.

In this suit for infringement of a patent the appellant, plaintiff in the District Court, appeals from a decree holding the patent void and denying relief. The parties will be referred to herein as plaintiff and defendant.

The plaintiff is a New York manufacturer of dental anesthetics and the holder of the patent in suit under assignment from Samuel D. Goldberg, a chemist in its employ. The patent, No. 2,051,349, is designated as a “Device for Preserving Local Anesthetic Solutions”. The defendant is a dealer in dental supplies and is charged with selling and distributing a device which infringes plaintiff’s patent. The alleged infringing device sold by defendant is manufactured by Jacob W. Frankel, doing business as the Minimax Company, and the suit is defended by this latter concern.

The application on which the patent in suit was issued 'describes it as a “device for preserving local anesthetics which have a tendency to decompose, and more particularly local anesthetics which are used for hypodermic injection”. As will hereinafter appear, it relates to a method or manner of packaging the anesthetic to exclude air therefrom during the time .between its manufacture and its ultimate use by a dentist or other user. At the present time and for some years it has been a common practice by manufacturers to prepare dental anesthetics for use by enclosing in a small glass tube or cartridge a proper amount of the anesthetic for one injection, these cartridges being .of such size and shape as that they can be inserted in a hypodermic syringe. A brief history of the steps which led to the now usual practice of administering the anesthetic in this way is helpful to an understanding of plaintiff’s claims.

The. essential constituents of the ordinary dental anesthetic in use are procaine .(commonly called novocaine) and epinephrin (also known as adrenalin) each performing a proper function in the desired result. The anesthetic solution when freshly prepared is completely colorless, but an epinephrin solution is quickly affected by contact with air and as this oxidation progresses it is evidenced by noticeable color changes. The solution first becomes a light brown, then pink, then tan and finally dark [905]*905brown or chocolate colored. This sensitivity to air as well as the characteristic color changes occasioned by it have been generally known among chemists for at least twenty-five years or more.

In an earlier day of the profession it was the custom of each dentist to prepare his own anesthetic solution from tablets, either for use on individual patients or by preparing a bottle of the solution which could be used from time to time. While the dentist could thus be sure of a fresh solution, this manner of preparation had certain disadvantages, including the difficulties of keeping the solution sterile and of insuring uniformity of strength. A development was the practice of manufacturers of mixing the solution in proper proportions in their laboratories and marketing it in individual doses contained in an ampoule consisting of a glass tube, the end of which was drawn together and sealed after the tube had been filled. This protected the epinephrin from oxidation and the anesthetic prepared in this manner showed no discoloration. In use, however, the end of the ampoule had to be broken off and the contents withdrawn into the syringe. The disadvantages of this were possible dangers from splinters of glass when the end of the ampoule was broken and the possibility of infection from the instrument or hand used in breaking it.

Finally about 1922 there was developed by Cook Laboratories the plunger type cartridge which is now in common use. This consists of a glass tube about the diameter of a lead pencil and approximately 3 inches long. The tube is filled with a single dose or injection of the prepared anesthetic solution and each end of the tube is closed with a rubber stopper or plug. While these stoppers are fitted tightly enough inside the tube to prevent leakage of the solution, they (or at least one of them) can be moved inside the tube by pressure. In using these tubes or cartridges the dentist simply removes one from a package containing a number of them and inserts it in his hypodermic syringe. The pointed upper end of the hypodermic needle punctures the rubber stopper in that end of the cartridge while the pressure upon the plunger or rod of the syringe pushes the stopper at the other end through the tube forcing the solution through the needle. This convenient and sanitary method of preparing and administering dental anesthetics has been in common use for many years and these cartridges are made and sold by a hundred or more manufacturers in the United States. It is admitted that there is no patent on this cartridge. It was the custom, in marketing the cartridges, to pack them in pasteboard boxes or cartons each containing about 100 cartridges. The plaintiff began manufacturing these cartridges in 1924, and in common with other manufacturers packed them for shipment in the pasteboard boxes up until 1935. The great majority of manufacturers still pack them in this way.

During the time this cartridge has been used it has been found that in some of the cartridges the contents would become discolored between the time of manufacture and the time of use. This discoloration showed the successive changes to light brown, tan, pink and dark brown heretofore mentioned. It appears that in the preparation of the anesthetic it has been the practice of manufacturers, including the plaintiff, to introduce a certain amount of sodium bi-sulphite for the purpose of retarding the oxidation of the epinephrin. It is testified that the oxygen in the air will be absorbed by the bi-sulphite before affecting the epinephrin and that the latter would not oxidize until the bi-sulphite was dissipated; that so long as any substantial amount of - the bi-sulphite remained the epinephrin would not discolor. And it further appears that the sole function of the sodium bi-sulphite in the solution is to , retard oxidation of the epinephrin. However the bi-sulphite merely retards oxidation and if any considerable time elapsed between the manufacture o'f the solution and its use a certain percentage of the cartridges developed discoloration by the time they reached the dentist’s hands. It became the custom in the trade that these discolored cartridges could be returned and exchanged without cost. The evidence as to the percentage of losses in this respect is far from definite and consists in the main of the experience of the plaintiff. It is claimed by the, plaintiff that in the regular course of its business the returns of discolored cartridges was from 5 per cent to 10 per cent. Losses on foreign shipments were generally larger because of the longer time elapsing between manufacture and use.

In the years 1932-1933, the plaintiff made some large shipments of these cartridges to England, of which about 70 per [906]*906cent were returned, resulting in a substantial financial loss. Because of this experience, the plaintiff determined to take steps to remedy the' situation and this led to the alleged invention. Dr. Goldberg, who is Director of Research for the plaintiff, states that he conducted a series of experiments to determine the cause of the discoloration. A reading of his testimony indicates that the experiments were limited to ascertaining whether air was leaking into the cartridges. He states that by experiments made in previous years he had determined that the discoloration of the fluid was not due to the rubber stoppers nor to the alkalinity of the glass tube.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Larsen Products Corp. v. Perfect Paint Products, Inc.
191 F. Supp. 303 (D. Maryland, 1961)
Boston Metals Co. v. Air Products Inc.
193 F.2d 535 (Fourth Circuit, 1952)
Martin v. Wyeth Inc.
96 F. Supp. 689 (D. Maryland, 1951)
Davison Chemical Corp. v. Joliet Chemicals, Inc.
179 F.2d 793 (Seventh Circuit, 1950)
General Electric Co. v. Jewel Incandescent Lamp Co.
47 F. Supp. 818 (D. New Jersey, 1942)

Cite This Page — Counsel Stack

Bluebook (online)
128 F.2d 904, 54 U.S.P.Q. (BNA) 40, 1942 U.S. App. LEXIS 3751, Counsel Stack Legal Research, https://law.counselstack.com/opinion/novocol-chemical-mfg-co-v-powers-anderson-dental-co-ca4-1942.